MX2013008531A - Nuevos compuestos de benzodioxol-piperazina. - Google Patents

Nuevos compuestos de benzodioxol-piperazina.

Info

Publication number
MX2013008531A
MX2013008531A MX2013008531A MX2013008531A MX2013008531A MX 2013008531 A MX2013008531 A MX 2013008531A MX 2013008531 A MX2013008531 A MX 2013008531A MX 2013008531 A MX2013008531 A MX 2013008531A MX 2013008531 A MX2013008531 A MX 2013008531A
Authority
MX
Mexico
Prior art keywords
piperazine compounds
novel
benzodioxole
novel benzodioxole
concerned
Prior art date
Application number
MX2013008531A
Other languages
English (en)
Inventor
Juergen Wichmann
Rosa Maria Rodriguez Sarmiento
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2013008531A publication Critical patent/MX2013008531A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

La presente invención se refiere a nuevos moduladores duales de los receptores de la 5-HT2A y de la D3, de la fórmula (I) (Ver Formula) en la que n, Y, R1, R2, R3 y R4 tienen los significados aquí definidos, así como las sales y ésteres farmacéuticamente aceptables de los mismos. La presente invención se refiere además a la obtención de los compuestos de la fórmula (I), a composiciones farmacéuticas que los contienen y a su utilización como medicamentos.
MX2013008531A 2011-02-17 2012-02-14 Nuevos compuestos de benzodioxol-piperazina. MX2013008531A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11154780 2011-02-17
PCT/EP2012/052440 WO2012110470A1 (en) 2011-02-17 2012-02-14 Novel benzodioxole piperazine compounds

Publications (1)

Publication Number Publication Date
MX2013008531A true MX2013008531A (es) 2013-08-12

Family

ID=45722618

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008531A MX2013008531A (es) 2011-02-17 2012-02-14 Nuevos compuestos de benzodioxol-piperazina.

Country Status (19)

Country Link
US (1) US8722683B2 (es)
EP (1) EP2675798B1 (es)
JP (1) JP2014505715A (es)
KR (1) KR20140006953A (es)
CN (1) CN103380122B (es)
AR (1) AR085236A1 (es)
AU (1) AU2012217150A1 (es)
BR (1) BR112013020656A2 (es)
CA (1) CA2823988A1 (es)
CO (1) CO6761304A2 (es)
CR (1) CR20130318A (es)
EA (1) EA201391124A1 (es)
EC (1) ECSP13012838A (es)
ES (1) ES2546430T3 (es)
HK (1) HK1189880A1 (es)
MA (1) MA34946B1 (es)
MX (1) MX2013008531A (es)
SG (1) SG192819A1 (es)
WO (1) WO2012110470A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106518841B (zh) * 2015-09-15 2019-03-05 浙江京新药业股份有限公司 环己烷衍生物或其立体异构体或盐及其制备与应用
EP3495363B1 (en) 2016-07-28 2023-08-23 Shionogi & Co., Ltd Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect
CN111801330B (zh) 2018-01-26 2024-04-05 盐野义制药株式会社 具有多巴胺d3受体拮抗作用的稠环化合物
WO2019146740A1 (ja) 2018-01-26 2019-08-01 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する環式化合物
CN111770754B (zh) * 2019-01-30 2023-09-19 江苏豪森药业集团有限公司 一种多环类衍生物调节剂、其制备方法和应用
CN110372557B (zh) * 2019-08-06 2021-05-18 上海勋和医药科技有限公司 环己烷胺类d3/d2受体部分激动剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
WO1996039133A1 (en) 1995-06-06 1996-12-12 Neurobiological Technologies, Inc. Novel n-substituted-2-amino-3',4'-methylene-dioxypropiophenones
EP1683790A1 (en) * 2005-01-24 2006-07-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) 3,4-dihydro-2-naphthamide derivatives as selective dopamine D3 ligands
HUP0500170A3 (en) * 2005-02-03 2007-11-28 Richter Gedeon Nyrt Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
BRPI0707960A2 (pt) 2006-02-17 2011-05-10 Hoffmann La Roche derivados de benzoil-piperidina como moduladores de 5ht2/d3, medicamento e uso dos mesmos
AU2007316249B2 (en) * 2006-10-31 2013-01-24 F. Hoffmann-La Roche Ag Ether derivatives dual modulators of the 5-HT2A and D3 receptors
AU2008280187B2 (en) * 2007-07-26 2013-05-16 F. Hoffmann-La Roche Ag Dual modulators of 5-HT2A and D3 receptors
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
AU2009294695B2 (en) * 2008-09-22 2012-09-13 F. Hoffmann-La Roche Ag Piperazine D3 and 5-HT2a receptor modulators
WO2010034648A1 (en) * 2008-09-23 2010-04-01 F. Hoffmann-La Roche Ag Pyridinylpiperazin derivatives useful as modulators of dopamine d3 receptors
US8586579B2 (en) * 2010-06-21 2013-11-19 Hoffmann-La Roche Inc. Anellated pyridine compounds
US8598357B2 (en) * 2011-03-03 2013-12-03 Hoffmann-La Roche Inc. Benzodioxole piperidine compounds

Also Published As

Publication number Publication date
EP2675798A1 (en) 2013-12-25
CO6761304A2 (es) 2013-09-30
HK1189880A1 (en) 2014-06-20
KR20140006953A (ko) 2014-01-16
BR112013020656A2 (pt) 2016-10-18
JP2014505715A (ja) 2014-03-06
MA34946B1 (fr) 2014-03-01
US8722683B2 (en) 2014-05-13
CA2823988A1 (en) 2012-08-23
AU2012217150A1 (en) 2013-05-02
EA201391124A1 (ru) 2014-02-28
ECSP13012838A (es) 2013-09-30
AR085236A1 (es) 2013-09-18
EP2675798B1 (en) 2015-07-01
CN103380122A (zh) 2013-10-30
CN103380122B (zh) 2015-04-29
SG192819A1 (en) 2013-09-30
US20130040948A1 (en) 2013-02-14
WO2012110470A1 (en) 2012-08-23
ES2546430T3 (es) 2015-09-23
CR20130318A (es) 2013-09-03

Similar Documents

Publication Publication Date Title
MX2014014229A (es) Pirrolidina-2-carboxamidas sustituidas.
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
MX363456B (es) Compuestos para tratar atrofia muscular espinal.
PH12016502081A1 (en) Compounds for treating spinal muscular atrophy
MX2014000626A (es) Nuevos derivados de indol sustituidos como moduladores de gamma secretasa.
PH12014501542B1 (en) Substituted pyrrolidine -2- carboxamides
IN2014CN04530A (es)
IN2015DN01119A (es)
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
MX2013008531A (es) Nuevos compuestos de benzodioxol-piperazina.
SG195106A1 (en) Trpv4 antagonists
MX2011013884A (es) Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas.
EA201400854A1 (ru) 4-(бензоимидазол-2-ил)тиазольные соединения и родственные аза производные
PH12018500378B1 (en) Novel annelated phenoxyacetamides
MX2011011303A (es) Derivados de isoxazol.
PH12016500322A1 (en) Amide derivatives as lysophosphatidic acid receptor antagonists
WO2014062838A3 (en) Pkm2 modulators and methods for their use
MX2013005966A (es) Nuevos compuestos de benzofurano.
MX345544B (es) Derivados de triazol como ligandos para receptores de acido gamma-aminobutirico (gaba).
MX2013011728A (es) Nuevos compuestos de benzofurano-piperidina.
EA201590069A1 (ru) Пиримидиноновые производные в качестве антималярийных средств
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
MX2013005965A (es) Nuevos compuestos de triazol iii.
GEP20156269B (en) New secondary 8-hydroxyquinoline-7- carboxamide derivatives

Legal Events

Date Code Title Description
FG Grant or registration